ENGAGe Blog
ESGO/ENGAGe together with WHO look forward to celebrating the launch of the Global Strategy to accelerate elimination of cervical cancer as a public health problem! We hope that you can join the global community…
Read more...
Information on maintenance treatment with PARP-inhibitors for high-grade serous ovarian cancer – both as first-line treatment and treatment in case of relapse. What has been approved by EMA (the…
Read more...
We are bringing you the Newsletter regarding the research on rare gynaecologica tumours – project in which ENGAGe members have participated and which is driven by scientist from Utrecht University…
Read more...
On September 20, 2020, we will turn the world purple. World GO Day raises awareness about gynaecological cancers worldwide Geneva, Switzerland, Sept. 11, 2020 – Cancer patient advocates and medical…
Read more...
Joint ESGO and ENGAGe webinar entitled Management of Patients before and after the Covid-19 pandemic will be held on Sept 8, 2020, 18:00-19:00 CEST. This webinar is primarily intended for doctors…
Read more...
Do you want to know the latest news about GO DAY 2020? Check our latest GO DAY NEWSLETTER or contact us on following email address: worldgoday@esgo.org
Read more...
This webinar will be held on July 15 from 17:00 – 18:00 CEST so please SAVE THE DATE! The program is as follows: 17:00 – 17:05 …
Read more...
It was experienced that there are substantial benefits, from both a patient’s and researcher’s perspective, of patient engagement in the research. However, it can be challenging for patients to find appropriate…
Read more...
The survey is conducted by ENGAGe member societies in cooperation with ESGO clinicians in different European countries to evaluate the effects of COVID with a patient perspective for the first…
Read more...
ESGO President Professor Philippe Morice and ESGO Vice-President Professor Nicole Concin are supporting ENGAGe members by this letter. ESGO clinicians are greeting and cheering up ENGAGe members during the…
Read more...
